TQB2928 Injection Combined With Penpulimab in Treatment of Advanced Malignant Tumors.

Clinical trial NCT06297642 · TERMINATED

Trial details

NCT number: NCT06297642
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignant Neoplasm

Start date: 2024-05-24
Primary completion: 2024-07-31
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.